192 related articles for article (PubMed ID: 23737042)
1. The protective effect of crocin on the amyloid fibril formation of Aβ42 peptide in vitro.
Ghahghaei A; Bathaie SZ; Kheirkhah H; Bahraminejad E
Cell Mol Biol Lett; 2013 Sep; 18(3):328-39. PubMed ID: 23737042
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
Singh PK; Maji SK
Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
[TBL] [Abstract][Full Text] [Related]
5. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth.
McLaurin J; Franklin T; Zhang X; Deng J; Fraser PE
Eur J Biochem; 1999 Dec; 266(3):1101-10. PubMed ID: 10583407
[TBL] [Abstract][Full Text] [Related]
6. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
7. Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species.
Ferrão-Gonzales AD; Robbs BK; Moreau VH; Ferreira A; Juliano L; Valente AP; Almeida FC; Silva JL; Foguel D
J Biol Chem; 2005 Oct; 280(41):34747-54. PubMed ID: 16041062
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+), within the physiological concentrations, selectively accelerates Abeta42 fibril formation and not Abeta40 in vitro.
Ahmad A; Muzaffar M; Ingram VM
Biochim Biophys Acta; 2009 Oct; 1794(10):1537-48. PubMed ID: 19595795
[TBL] [Abstract][Full Text] [Related]
9. Pyroglutamate-Modified Amyloid-β(3-42) Shows α-Helical Intermediates before Amyloid Formation.
Dammers C; Reiss K; Gremer L; Lecher J; Ziehm T; Stoldt M; Schwarten M; Willbold D
Biophys J; 2017 Apr; 112(8):1621-1633. PubMed ID: 28445753
[TBL] [Abstract][Full Text] [Related]
10. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.
Jan A; Gokce O; Luthi-Carter R; Lashuel HA
J Biol Chem; 2008 Oct; 283(42):28176-89. PubMed ID: 18694930
[TBL] [Abstract][Full Text] [Related]
11. The potential inhibitory effect of β-casein on the aggregation and deposition of Aβ
Hojati S; Ghahghaei A; Lagzian M
J Biomol Struct Dyn; 2018 Jun; 36(8):2118-2130. PubMed ID: 28633568
[TBL] [Abstract][Full Text] [Related]
12. Aβ(39-42) modulates Aβ oligomerization but not fibril formation.
Gessel MM; Wu C; Li H; Bitan G; Shea JE; Bowers MT
Biochemistry; 2012 Jan; 51(1):108-17. PubMed ID: 22129303
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42.
Sato T; Kienlen-Campard P; Ahmed M; Liu W; Li H; Elliott JI; Aimoto S; Constantinescu SN; Octave JN; Smith SO
Biochemistry; 2006 May; 45(17):5503-16. PubMed ID: 16634632
[TBL] [Abstract][Full Text] [Related]
14. E22G Pathogenic Mutation of β-Amyloid (Aβ) Enhances Misfolding of Aβ40 by Unexpected Prion-like Cross Talk between Aβ42 and Aβ40.
Yoo BK; Xiao Y; McElheny D; Ishii Y
J Am Chem Soc; 2018 Feb; 140(8):2781-2784. PubMed ID: 29425039
[TBL] [Abstract][Full Text] [Related]
15. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
16. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Wang L; Eom K; Kwon T
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
[TBL] [Abstract][Full Text] [Related]
17. Steady-state and time-resolved Thioflavin-T fluorescence can report on morphological differences in amyloid fibrils formed by Aβ(1-40) and Aβ(1-42).
Lindberg DJ; Wranne MS; Gilbert Gatty M; Westerlund F; Esbjörner EK
Biochem Biophys Res Commun; 2015 Mar; 458(2):418-23. PubMed ID: 25660454
[TBL] [Abstract][Full Text] [Related]
18. Non-micellar ganglioside GM1 induces an instantaneous conformational change in Aβ
Kumar M; Ivanova MI; Ramamoorthy A
Biophys Chem; 2023 Oct; 301():107091. PubMed ID: 37549471
[TBL] [Abstract][Full Text] [Related]
19. Critical role of interfaces and agitation on the nucleation of Abeta amyloid fibrils at low concentrations of Abeta monomers.
Morinaga A; Hasegawa K; Nomura R; Ookoshi T; Ozawa D; Goto Y; Yamada M; Naiki H
Biochim Biophys Acta; 2010 Apr; 1804(4):986-95. PubMed ID: 20100601
[TBL] [Abstract][Full Text] [Related]
20. Charged surfactants induce a non-fibrillar aggregation pathway of amyloid-beta peptide.
Loureiro JA; Rocha S; Pereira Mdo C
J Pept Sci; 2013 Sep; 19(9):581-7. PubMed ID: 23922329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
